Overview

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Status:
Completed

Trial end date:
2003-01-01

Target enrollment:

Participant gender:

Summary

The purposes of this study are to determine whether an investigational drug can help patients suffering from major depression with pain symptoms, and gather data on the safety of the investigational drug including any side effects that might be associated with it.

Phase:

Phase 3

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Duloxetine Hydrochloride